John Pacheco, founder of Financial American Corporation, contributes to Make-A-Wish Arizona and the Arizona Humane Society. John Pacheco also supports Phoenix Children’s Hospital (PCH). Contributions made to the PCH are applied to three critical areas:
Molecular Medicine: PCH sponsors research at the Ronald A. Matricaria Institute of Molecular Medicine to develop prevention methods and cures for various childhood diseases. Scientists are currently developing treatment options that allow medical professionals to personalize medications and therapies based on a person’s DNA.
Emergency and Trauma: The hospital stands out as the only provider in Arizona with a Level I Pediatric Trauma Center. It employs expert emergency and trauma physicians to care for patients with critical illnesses as well as children who have endured a major accident.
Hope Fund: It is not uncommon for PCH to be faced with a challenge or receive an unprecedented opportunity requiring additional monetary support. The Hope Fund allows donors to assist PCH operations without any restriction on where donations are spent. This ensures PCH can utilize funds where they are most needed.
A graduate of the Franklin Pierce Law Center, John W. Pacheco has more than three decades of experience in real estate development and investment. In 1978, he founded Financial American Corporation, where he serves as chief executive officer. John W. Pacheco is also an active philanthropist, supporting such national organizations as the Leukemia and Lymphoma Society (LLS).
The largest volunteer health organization in the world, LLS is committed to raising awareness and funds for blood cancer research. Among the organization’s various programs is the Patti Robinson Kaufmann First Connection Program, which offers peer-to-peer support for individuals who have recently received a cancer diagnosis. The program draws on the experience of volunteer survivors, each of whom is trained in basic counseling and educated on a wide variety of local resources. Participants benefit from the perspective of someone who has experienced cancer firsthand, while family members can connect with those who have been in similar positions.
Whenever possible, the program matches participants by diagnosis, age, and gender, ensuring an appropriate fit for everyone involved.
A veteran of the investment industry, John W. Pacheco founded Financial American Corporation and served as chief executive officer for more than three decades. John W. Pacheco now leverages his success to contribute to a number of organizations, including the Phoenix Children’s Hospital.
The Phoenix Children’s Hospital currently seeks financial support in the areas of emergency and trauma, the Hope Fund, and molecular medicine. The following explains more about molecular medicine.
1. Molecular medicine allows health-care professionals to look at an individual’s deoxyribonucleic acid (DNA) to plan a course treatment. This type of science is the first of its kind that caters specifically to individual patient care.
2. This innovation utilizes gene sequencing and testing to determine sensitivity to new drugs. Identifying potential mutations, physicians can administer treatments that are less likely to cause adverse side effects.
3. By analyzing genetic susceptibility to diseases, molecular medicine paves the way for researchers to develop future methods that will aid in the prevention of cancer and other illnesses.
John W. Pacheco serves as chief executive officer of Financial American Corporation, a Scottsdale, Arizona-based firm he founded in 1978. Outside of his professional activities, John W. Pacheco supports the work of a number of philanthropic organizations, including the Juvenile Diabetes Research Foundation (JDRF).
In a recent press release, JDRF announced that it has launched a two-year partnership with Eli Lilly and Company to provide increased support for patients diagnosed with type 1 diabetes (T1D). Through the partnership, JDRF will receive $1.8 million for its various diabetes support programs and events, including Bag of Hope, the TypeOneNation Summits, and the JDRF One Walk.
The funds will also help JDRF continue to distribute its teen and school advisory toolkits and support the Children’s Congress, which brings 150 child delegates and their families to Washington, DC, every two years to raise awareness about the importance T1D research funding. Eli Lilly has been instrumental in supporting these and other JDRF initiatives since it became one of the group’s national sponsors more than four years ago.